Pharmaceutical

Atossa Therapeutics progresses Phase II preventative breast cancer therapy

Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.

Jan 27, 2024 - 18:00
Atossa Therapeutics progresses Phase II preventative breast cancer therapy
Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.
Read the original article

Tags:

Previous Article

CAR-T therapies and cancer risk: No easy answers for the FDA

Next Article

FDA expands approval of Dupixent for eosinophilic esophagitis in children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: VC turmoil, GLP-1 competition, & the war on recovery

Listen: VC turmoil, GLP-1 competition, & the war on rec...

Mar 8, 2024

STAT+: Pharmalittle: Novartis is latest drugmaker to sue over Medicare negotiations; Illumina names a new CEO

STAT+: Pharmalittle: Novartis is latest drugmaker to su...

Sep 6, 2023

STAT+: Pfizer plans to depart BIO

STAT+: Pfizer plans to depart BIO

Dec 5, 2023